Table 1

Demographic characteristics of thestudy participants
Characteristic Frequency n (%) n= 248 P value
Users = 129 (52.02)S.E (3.17%) Non-users = 119 (47.98)SE (3.17%) Total = 248 (100)
Age (years)
<20 15 (6.05) S.E (1.51%) 7 (2.82) S.E (1.05%) 22 (8.87) S.E (0.57%) P = 0.113
20-25 60 (24.2) SE (2.72%) 37 (14.91) SE (2.26%) 97 (39.11) SE (3.1%) P = 0.021
26-30 30 (12.09) SE (2.07%) 41 (16.62) SE (2.36%) 71 (28.63) SE (2.87%) P = 0.183
31-40 21 (8.47) SE (1.77%) 30 (12.09) SE (2.07%) 51 (20.56) SE (2.57%) P = 0.206
>40 3 (1.21) SE (0.69%) 4 (1.61) SE (0.8%) 7 (2.82) SE (1.51%) P = 0.714
Level of Education
None 0 (0) 0(0) 0 (0)
Primary 7 (2.82) SE (1.05%) 6 (2.42) SE (0.98%) 13 (5.24) SE (1.41%) P = 0.7774
Secondary 114 (46) SE (3.16%) 99 (39.89) SE (3.11%) 213 (85.89) SE (2.21%) P = 0.244
Tertiary 8 (3.22) SE (1.12%) 14 (5.65) SE (1.47%) 22 (8.87) SE (0.57%) P = 0.205
Employment
Housewife 83 (33.47) SE (3.00%) 63 (23.4) SE (2.69%) 146 (56.87) SE (3.14%) P = 0.094
Self-Employed 22 (8.87) SE (0.57%) 32 (12.9) SE (2.13%) 54 (21.77) SE (2.62%) P = 0.193
Formally employed 13 (5.24) SE (1.41%) 20 (8.07) SE (1.73%) 33 (13.31) SE (2.28%) P = 0.216
Student 11 (4.44) SE (1.31%) 4 (1.61) SE (0.8%) 15 (6.05) SE (1.51%) P = 0.107
Parity
1 58 (23.39) SE (2.69%) 29 (11.69) SE (2.04%) 87 (35.08) SE (3.03%) P = 0.004
2 45 (18.15) SE (2.45%) 45 (18.15) SE (2.45%) 90 (36.29) SE (3.05%) P = 1.000
3 20 (8.06) SE (1.73%) 36 (14.52) SE (2.24%) 56 (22.58) SE (2.65%) P = 0.044
4 5 (2.02) SE (0.89%) 7 (2.82) SE (1.05%) 12 (4.84) SE (1.36%) P = 0.585
5 1 (0.41) SE (0.41%) 1 (0.41) SE (0.41%) 2 (0.81) SE (0.57%) P = −*
6 0 (0) 1 (0.41) SE (0.41%) 1 (0.40) SE (0.41%) P = −*
Gravida
1 52 (21) SE (2.59%) 23 (9.27) SE (1.84) 75 (30.24) SE (2.92%) P = 0.002
2 41 (16.5) SE (2.36%) 43 (17.34) SE (2.4%) 84 (33.87) SE (3.00%) P = 0.855
3 27 (10.89) SE (1.98%) 40 (16.13) SE (2.34%) 67 (27.02) SE (2.82%) P = 0.108
4 8 (3.23) SE (1.12%) 10 (4.03)SE (1.25%) 18 (7.26) SE (1.65%) P = 0.555
5 1 (0.41) SE (0.41%) 1 (0.41) SE (0.41%) 2 (0.81) SE (0.57%) P = −*
6 2 (0.81) SE (0.57%) 0 (0) 2 (0.81) SE (0.57%) P = −*
Tribe
Zezuru 60 (24.19) SE (2.72%) 55 (22.18) SE (2.64%) 115 (46.37) SE (3.17%) P = 0.668
Karanga 18 (7.26) SE (1.65%) 14 (5.64) SE (1.47%) 32 (12.90) SE (2.13%) P = 0.558
Maungwe 12 (4.84) SE (1.36%) 11 (4.43) SE (1.31%) 23 (9.27) SE (1.84%) P = 0.661
Manyika 9 (3.63) SE (1.19%) 14 (5.64) SE (1.47%) 23 (9.27) SE (1.84) P = 0.303
Ndebele 5 (2.02) SE (0.89%) 4 (1.61) SE (0.8%) 9 (3.63) SE (1.19%) P = 0.720
Korekore 13 (5.24) SE (1.41%) 11 (4. 44) SE (1.31%) 24 (9.68) SE (1.88%) P = 0.696
Ndau 2 (0.81) SE (0.57%) 3 (1.21) SE (0.69%) 5 (2.02) SE (0.89%) P = 0.661
Toko 7 (2.82) S.E (1.05%) 4 (1.61) SE (0.8%) 11 (4.44) SE (1.31%) P = 0.370
Foreigner 3 (1.21) SE (0.69%) 3 (1.21) SE (0.69%) 6 (2.42) SE (0.98%) P = 1.000
Area of Residence
Budiriro 11 (4.44) SE (1.31%) 9 (3.63) SE (1.19%) 20 (8.06) SE (1.73%) P = 0.656
Mbare 15 (6.05) SE (1.51%) 5 (2.02) SE (0.89%) 20 (8.06) SE (1.73%) P = 0.046
Glen View 12 (4.84) SE (1.36%) 8 (3.22) SE (1.12%) 20 (8.06) SE (1.73%) P = 0.380
Hatcliffe 11 (4.44) SE (1.31%) 9 (3.63) SE (1.19%) 20 (8.06) SE (1.73%) P = 0.656
Highfield 24 (9.68) SE (1.88%) 19 (7.66) SE (1.69%) 43 (17.34) SE (2.4%) P = 0.443
Kambuzuma 12 (4.84) SE (1.36%) 8 (3.22) SE (1.12%) 20 (8.06) SE (1.73%) P = 0.380
Kuwadzana 9 (3.63) SE (1.19%) 11 (4.44) SE (1.31%) 20 (8.06) SE (1.73%) P = 0.656
Mabvuku/Tafara 6 (2.42) SE (0.98%) 14 (5.64) SE (1.47%) 20 (8.06) SE (1.73%) P = 0.097
Mufakose 10 (4.03) SE (1.25%) 15 (6.05) SE (1.51%) 25 (10.08) SE (1.73%) P = 0.327
Dzivarasekwa 6 (2.42) SE (0.98%) 14 (5.64) SE (1.47%) 20 (8.06) SE (1.73%) P = 0.097
Warren Park 13 (5.24) SE (1.41%) 7 (2.82) S.E (1.05%) 20 (8.06) SE (1.73%) P = 0.199

* Not enough observations to test for significance. Table 1 shows the demographic characteristics of the study population; their age, level of education and employment status according to whether they were prenatal users of TM interventions (users) or non-users.

SE = Standard Error.

Mureyi et al.

Mureyi et al. BMC Complementary and Alternative Medicine 2012 12:164   doi:10.1186/1472-6882-12-164

Open Data